These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21452985)
1. Bioanalytical interferences in immunoassays for antibody biotherapeutics. Pendley C; Shankar G Bioanalysis; 2011 Apr; 3(7):703-6. PubMed ID: 21452985 [No Abstract] [Full Text] [Related]
2. [Antibody interference in immunoassays with markers]. Sapin R Ann Biol Clin (Paris); 1990; 48(6):361-4. PubMed ID: 2221494 [TBL] [Abstract][Full Text] [Related]
3. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies. Valentin MA; Ma S; Zhao A; Legay F; Avrameas A J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130 [TBL] [Abstract][Full Text] [Related]
4. Challenges in developing bioanalytical assays for characterization of antibody-drug conjugates. Stephan JP; Kozak KR; Wong WL Bioanalysis; 2011 Mar; 3(6):677-700. PubMed ID: 21417735 [TBL] [Abstract][Full Text] [Related]
5. Clinical repercussions of analytical interferences due to aldosterone antagonists in digoxin immunoassays: an assessment. Cobo A; Martín-Suarez A; Calvo MV; Domínguez-Gil A; de Gatta MM Ther Drug Monit; 2010 Apr; 32(2):169-76. PubMed ID: 20216123 [TBL] [Abstract][Full Text] [Related]
6. Endogenous interference in immunoassays in clinical chemistry. A review. Weber TH; Käpyaho KI; Tanner P Scand J Clin Lab Invest Suppl; 1990; 201():77-82. PubMed ID: 2244186 [TBL] [Abstract][Full Text] [Related]
7. Interference in immunoassays to support therapeutic antibody development in preclinical and clinical studies. Schwickart M; Vainshtein I; Lee R; Schneider A; Liang M Bioanalysis; 2014; 6(14):1939-51. PubMed ID: 24806787 [TBL] [Abstract][Full Text] [Related]
9. Interference in immunoassay. Nickoloff EL Crit Rev Clin Lab Sci; 1984; 21(3):255-67. PubMed ID: 6391818 [TBL] [Abstract][Full Text] [Related]
10. Immunoassays for collagenase-mediated cleavage of type I and II collagens. Billinghurst RC; Ionescu M; Poole AR Methods Mol Biol; 2010; 622():349-66. PubMed ID: 20135293 [TBL] [Abstract][Full Text] [Related]
11. User configurable microfluidic device for multiplexed immunoassays based on DNA-directed assembly. Schroeder H; Adler M; Gerigk K; Müller-Chorus B; Götz F; Niemeyer CM Anal Chem; 2009 Feb; 81(3):1275-9. PubMed ID: 19123774 [TBL] [Abstract][Full Text] [Related]
12. On-chip native gel electrophoresis-based immunoassays for tetanus antibody and toxin. Herr AE; Throckmorton DJ; Davenport AA; Singh AK Anal Chem; 2005 Jan; 77(2):585-90. PubMed ID: 15649057 [TBL] [Abstract][Full Text] [Related]
13. False-positive results corrected by the use of heterophilic antibody-blocking reagent in thyroglobulin immunoassays. Massart C; Corcuff JB; Bordenave L Clin Chim Acta; 2008 Feb; 388(1-2):211-3. PubMed ID: 17963702 [No Abstract] [Full Text] [Related]
14. Recognition of anti-mycolic acid antibody at self-assembled mycolic acid antigens on a gold electrode: a potential impedimetric immunosensing platform for active tuberculosis. Mathebula NS; Pillay J; Toschi G; Verschoor JA; Ozoemena KI Chem Commun (Camb); 2009 Jun; (23):3345-7. PubMed ID: 19503865 [TBL] [Abstract][Full Text] [Related]
15. Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods. Bowsher RR; Nowatzke WL Bioanalysis; 2011 Apr; 3(8):883-98. PubMed ID: 21510762 [TBL] [Abstract][Full Text] [Related]
16. A graphene-based Au(111) platform for electrochemical biosensing based catalytic recycling of products on gold nanoflowers. Liu B; Tang D; Tang J; Su B; Li Q; Chen G Analyst; 2011 Jun; 136(11):2218-20. PubMed ID: 21384013 [TBL] [Abstract][Full Text] [Related]